2005
DOI: 10.1016/j.imlet.2005.04.006
|View full text |Cite
|
Sign up to set email alerts
|

Antibodies against a Leishmania infantum peroxiredoxin as a possible marker for diagnosis of visceral leishmaniasis and for monitoring the efficacy of treatment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

3
28
0

Year Published

2006
2006
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 34 publications
(31 citation statements)
references
References 26 publications
(36 reference statements)
3
28
0
Order By: Relevance
“…Thus, our results suggest that the dynamics of antibodies against recombinant proteins may be more useful than the dynamics of antibodies against CTLA for assessing clinical improvement after treatment, as described in human patients treated for visceral leishmaniasis. In accordance with our results, antibodies against the recombinant proteins rKMPII 25 and Li cTXNPx, a protein similar to TRYP, 26 decreased significantly after treatment of patients with visceral leishmaniasis, conversely to serologic results with crude Leishmania antigen.…”
Section: Discussionsupporting
confidence: 91%
“…Thus, our results suggest that the dynamics of antibodies against recombinant proteins may be more useful than the dynamics of antibodies against CTLA for assessing clinical improvement after treatment, as described in human patients treated for visceral leishmaniasis. In accordance with our results, antibodies against the recombinant proteins rKMPII 25 and Li cTXNPx, a protein similar to TRYP, 26 decreased significantly after treatment of patients with visceral leishmaniasis, conversely to serologic results with crude Leishmania antigen.…”
Section: Discussionsupporting
confidence: 91%
“…For comparison, the same cohort was tested for the presence of antibodies against SPLA, SALA, or LimTXNPx. The antigen concentration and serum dilution used in all ELISA assays were previously optimized (10,28,35). Therefore, we used 5 g/ml of each recombinant antigen and 10 g/ml of both Leishmania promastigote and amastigote soluble antigens as optimal concentrations.…”
Section: Resultsmentioning
confidence: 99%
“…Nevertheless, rK39 performs suboptimally in asymptomatic cases with proven infection (22). We have recently described the L. infantum cytosolic tryparedoxin peroxidase (LicTXNPx) antigen, a member of unique enzymatic Leishmania cascades for detoxification of peroxides (8), as a highly immunogenic probe during natural human or experimental canine infections (28,35). Our previous studies indicated that anti-LicTXNPx antibodies were present in both symptomatic and asymptomatic experimental canine infections, making this antigen a good candidate marker for both clinical and subclinical Leishmania infections (35).…”
mentioning
confidence: 99%
“…Tryparedoxin peroxidase belongs to a family of proteins called peroxiredoxins, which are associated with parasite virulence and have a high antigenicity during the active disease. Previous studies have shown the antigenicity of peroxiredoxins in dogs and humans infected by Leishmania infantum or L. braziliensis (46,47). Khosravi et al showed that a realtime PCR using the tryparedoxin peroxidase gene was specific for CL diagnosis (48).…”
Section: Discussionmentioning
confidence: 99%